PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by Xuorescent in situ hybridization

Sarah N. Dumont, Alexander J. Lazar, Julia A. Bridge, Robert S. Benjamin, Jonathan C. Trent

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose In pediatric alveolar rhabdomyosarcoma, the PAX3-FOXO1 and PAX7-FOXO1 gene fusions are prognostic indicators, while little is known concerning this disease in older patients. To determine whether PAX3/7-FOXO1 fusion gene status correlates with outcome in adolescent, young adult, and adult rhabdomyosarcoma patients, the histological, immunohistochemical, and clinical characteristics of 105 patients followed at The University of Texas MD Anderson Cancer Center from 1957 to 2001 were evaluated. Methods The samples were assembled into a tissue microarray, and fusion gene status was determined by Xuorescence in situ hybridization using PAX3, PAX7, and FOXO1 loci-speciWc probes. The disease characteristics and speciWc gene fusion were correlated with patient outcomes using the log-rank test. Results Fifty-two percent of the samples exhibited a PAX3-FOXO1 fusion, 15% the PAX7-FOXO1 fusion, and 33% were negative for a rearrangement of these loci. The presence of PAX3/7-FOXO1 translocation was signiWcantly associated with a higher frequency of metastatic disease. Although a statistically signiWcant correlation between the PAX3/7-FOXO1 fusion gene status and overall survival was not identiWed, there was a trend toward better outcomes for patients with fusion-negative RMS. Conclusions Therefore, identiWcation of a FOXO1 fusion appears to be an interesting tool for predicting outcomes in older rhabdomyosarcoma patients and is worth further investigations in this rare subgroup of RMS population.

Original languageEnglish (US)
Pages (from-to)213-220
Number of pages8
JournalJournal of Cancer Research and Clinical Oncology
Volume138
Issue number2
DOIs
StatePublished - Feb 1 2012

Fingerprint

Rhabdomyosarcoma
Gene Fusion
In Situ Hybridization
Population
Alveolar Rhabdomyosarcoma
Young Adult
Pediatrics
Survival
Neoplasms

Keywords

  • Chromosomal rearrangement
  • Fluorescent in situ hybridization
  • PAX-FOXO1
  • Rhabdomyosarcoma
  • Tissue microarray

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by Xuorescent in situ hybridization. / Dumont, Sarah N.; Lazar, Alexander J.; Bridge, Julia A.; Benjamin, Robert S.; Trent, Jonathan C.

In: Journal of Cancer Research and Clinical Oncology, Vol. 138, No. 2, 01.02.2012, p. 213-220.

Research output: Contribution to journalArticle

Dumont, Sarah N. ; Lazar, Alexander J. ; Bridge, Julia A. ; Benjamin, Robert S. ; Trent, Jonathan C. / PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by Xuorescent in situ hybridization. In: Journal of Cancer Research and Clinical Oncology. 2012 ; Vol. 138, No. 2. pp. 213-220.
@article{30ba4f538ad74c4db443fd164076eaed,
title = "PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by Xuorescent in situ hybridization",
abstract = "Purpose In pediatric alveolar rhabdomyosarcoma, the PAX3-FOXO1 and PAX7-FOXO1 gene fusions are prognostic indicators, while little is known concerning this disease in older patients. To determine whether PAX3/7-FOXO1 fusion gene status correlates with outcome in adolescent, young adult, and adult rhabdomyosarcoma patients, the histological, immunohistochemical, and clinical characteristics of 105 patients followed at The University of Texas MD Anderson Cancer Center from 1957 to 2001 were evaluated. Methods The samples were assembled into a tissue microarray, and fusion gene status was determined by Xuorescence in situ hybridization using PAX3, PAX7, and FOXO1 loci-speciWc probes. The disease characteristics and speciWc gene fusion were correlated with patient outcomes using the log-rank test. Results Fifty-two percent of the samples exhibited a PAX3-FOXO1 fusion, 15{\%} the PAX7-FOXO1 fusion, and 33{\%} were negative for a rearrangement of these loci. The presence of PAX3/7-FOXO1 translocation was signiWcantly associated with a higher frequency of metastatic disease. Although a statistically signiWcant correlation between the PAX3/7-FOXO1 fusion gene status and overall survival was not identiWed, there was a trend toward better outcomes for patients with fusion-negative RMS. Conclusions Therefore, identiWcation of a FOXO1 fusion appears to be an interesting tool for predicting outcomes in older rhabdomyosarcoma patients and is worth further investigations in this rare subgroup of RMS population.",
keywords = "Chromosomal rearrangement, Fluorescent in situ hybridization, PAX-FOXO1, Rhabdomyosarcoma, Tissue microarray",
author = "Dumont, {Sarah N.} and Lazar, {Alexander J.} and Bridge, {Julia A.} and Benjamin, {Robert S.} and Trent, {Jonathan C.}",
year = "2012",
month = "2",
day = "1",
doi = "10.1007/s00432-011-1089-7",
language = "English (US)",
volume = "138",
pages = "213--220",
journal = "Zeitschrift fur Krebsforschung und Klinische Onkologie",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by Xuorescent in situ hybridization

AU - Dumont, Sarah N.

AU - Lazar, Alexander J.

AU - Bridge, Julia A.

AU - Benjamin, Robert S.

AU - Trent, Jonathan C.

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Purpose In pediatric alveolar rhabdomyosarcoma, the PAX3-FOXO1 and PAX7-FOXO1 gene fusions are prognostic indicators, while little is known concerning this disease in older patients. To determine whether PAX3/7-FOXO1 fusion gene status correlates with outcome in adolescent, young adult, and adult rhabdomyosarcoma patients, the histological, immunohistochemical, and clinical characteristics of 105 patients followed at The University of Texas MD Anderson Cancer Center from 1957 to 2001 were evaluated. Methods The samples were assembled into a tissue microarray, and fusion gene status was determined by Xuorescence in situ hybridization using PAX3, PAX7, and FOXO1 loci-speciWc probes. The disease characteristics and speciWc gene fusion were correlated with patient outcomes using the log-rank test. Results Fifty-two percent of the samples exhibited a PAX3-FOXO1 fusion, 15% the PAX7-FOXO1 fusion, and 33% were negative for a rearrangement of these loci. The presence of PAX3/7-FOXO1 translocation was signiWcantly associated with a higher frequency of metastatic disease. Although a statistically signiWcant correlation between the PAX3/7-FOXO1 fusion gene status and overall survival was not identiWed, there was a trend toward better outcomes for patients with fusion-negative RMS. Conclusions Therefore, identiWcation of a FOXO1 fusion appears to be an interesting tool for predicting outcomes in older rhabdomyosarcoma patients and is worth further investigations in this rare subgroup of RMS population.

AB - Purpose In pediatric alveolar rhabdomyosarcoma, the PAX3-FOXO1 and PAX7-FOXO1 gene fusions are prognostic indicators, while little is known concerning this disease in older patients. To determine whether PAX3/7-FOXO1 fusion gene status correlates with outcome in adolescent, young adult, and adult rhabdomyosarcoma patients, the histological, immunohistochemical, and clinical characteristics of 105 patients followed at The University of Texas MD Anderson Cancer Center from 1957 to 2001 were evaluated. Methods The samples were assembled into a tissue microarray, and fusion gene status was determined by Xuorescence in situ hybridization using PAX3, PAX7, and FOXO1 loci-speciWc probes. The disease characteristics and speciWc gene fusion were correlated with patient outcomes using the log-rank test. Results Fifty-two percent of the samples exhibited a PAX3-FOXO1 fusion, 15% the PAX7-FOXO1 fusion, and 33% were negative for a rearrangement of these loci. The presence of PAX3/7-FOXO1 translocation was signiWcantly associated with a higher frequency of metastatic disease. Although a statistically signiWcant correlation between the PAX3/7-FOXO1 fusion gene status and overall survival was not identiWed, there was a trend toward better outcomes for patients with fusion-negative RMS. Conclusions Therefore, identiWcation of a FOXO1 fusion appears to be an interesting tool for predicting outcomes in older rhabdomyosarcoma patients and is worth further investigations in this rare subgroup of RMS population.

KW - Chromosomal rearrangement

KW - Fluorescent in situ hybridization

KW - PAX-FOXO1

KW - Rhabdomyosarcoma

KW - Tissue microarray

UR - http://www.scopus.com/inward/record.url?scp=84857048155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857048155&partnerID=8YFLogxK

U2 - 10.1007/s00432-011-1089-7

DO - 10.1007/s00432-011-1089-7

M3 - Article

VL - 138

SP - 213

EP - 220

JO - Zeitschrift fur Krebsforschung und Klinische Onkologie

JF - Zeitschrift fur Krebsforschung und Klinische Onkologie

SN - 0171-5216

IS - 2

ER -